Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab with combination chemotherapy in stage II-IV diffuse large B-cell non-Hodgkin's lymphoma has completed wi…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating the combination of tanespimycin and bortezomib in adults with advanced solid tumors or lymphomas; the study was ter…
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating combination chemotherapy and rituximab with pegfilgrastim followed by rituximab in large B-cell non-Hodgkin's lymph…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). [Phase 2]
A Phase 2 trial evaluated the safety and efficacy of adding AMD3100 to a G-CSF mobilization regimen in patients with non-Hodgkin lymphoma, H…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 study evaluating iodine-131 labeled tositumomab with rituximab and chemotherapy in older patients with stage II-IV Non-Hodgkin lymph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating CCI-779 (temsirolimus) in patients with recurrent or refractory B-cell non-Hodgkin lymphoma or chronic l…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).
Long-term follow-up analysis of non-Hodgkin's lymphoma patients who received Plerixafor or placebo in the AMD3100-3101 trial to assess outco…
-
CLINICAL_TRIALS research · 2014-02-07Clinical Trial Update: Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)
An observational clinical trial update studying the association between B-cell non-Hodgkin lymphomas and hepatitis C virus infection, sponso…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM) [Phase 1, Phase 2]
Clinical trial GS-9219 in chronic lymphocytic leukemia, non-Hodgkin's lymphoma, and multiple myeloma (Phase 1/2) has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms [Phase 4]
A Phase 4 study evaluated whether weight-based dosing of plerixafor is preferable to a fixed dose in adults with non-Hodgkin lymphoma weighi…
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab [NA]
Completed clinical trial assessing the immune response to influenza vaccination in patients with non-Hodgkin lymphoma treated with rituximab…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 results for the combination of temsirolimus (CCI-779) and rituximab in relapsed or refractory non-Hodgkin lymphoma have been reporte…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
This document summarizes a Phase 2 clinical trial of rituximab with a vaccine therapy and GM-CSF in patients with Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating a four-drug combination of gemcitabine hydrochloride, rituximab, oxaliplatin, and lenalidomide for relapse…
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial update evaluating valproic acid in patients with previously treated non-Hodgkin lymphoma, Hodgkin lymphoma, or chro…
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma [Phase 1]
A Phase 1 clinical trial of a radiolabeled monoclonal antibody for patients with previously treated large cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-01Clinical Trial Update: A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation [Phase 1]
A Phase 1 pediatric study evaluating a plerixafor-containing regimen as part of a second allogeneic stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial update evaluating a Genitope gp100 vaccine with rituximab and sargramostim for patients with refractory or progress…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
This update summarizes a Phase 2 clinical trial evaluating epratuzumab as treatment for Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating a combination of biological therapy and monoclonal antibody therapy in patients with relapsed or refractory Non-Hod…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma [Phase 3]
An update on a Phase 3 trial evaluating combination chemotherapy for children with Non-Hodgkin lymphoma, with the current status not disclos…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating epratuzumab for Non-Hodgkin lymphoma; current status/details are not provided.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides [Phase 2]
This entry provides an update on a Phase 2 trial of combination chemotherapy for advanced or recurrent mycosis fungoides. Mycosis fungoides …
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
This clinical trial update describes a Phase 2 study of a monoclonal antibody therapy for patients with relapsed or refractory Non-Hodgkin l…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Beta Alethine in Treating Patients With Low-Grade Lymphoma [Phase 1, Phase 2]
This clinical trial update covers the Phase 1/Phase 2 study of Beta Alethine in patients with low-grade non-Hodgkin lymphoma.